The North America Omics Lab Services Market should witness market growth of 12.4% CAGR during the forecast period (2022-2028).
The Omics research has mostly helped the area of cancer, and one recently established use of NGS clinical testing is for the measurement of circulating tumor DNA (ctDNA) from plasma. There are several NGS technologies that may be applied, including Cancer Personalized Profiling by deep sequencing. Recent advancements in high-throughput RNA sequencing have highlighted the significance of transcriptomics in biological and clinical research. Transcriptomics may be carried out utilizing microarrays or RNA sequencing using NGS technology.
Omics labs have become an essential tool for the prognosis, diagnosis, and treatment of a wide range of diseases; however, the sample sent to omics labs are significantly impacted by supply chain and logistics issues, a lack of skilled professionals with the capacity to handle samples and these issues. Tens of thousands to millions of molecular measurements may be found in omics databases.
Usually, researchers begin by making feature selection, which entails selecting a subset of the data that seem to be connected to the characteristic or outcome or that are presumed to be physiologically relevant based on prior experience. Using just this subset of the data, a fully described computer model may be developed to forecast the clinical outcome based on the omics measurements.
North America is witnessing a massive adoption of new sequencing technology and a shift toward tailored medications. In addition, government assistance is critical. For example, the Biden Administration announced a USD 1.7 billion investment to Fight COVID-19 Variants in April 2021, with USD 1 billion going to expand genomic sequencing and USD 400 million going to support innovation initiatives like the launch of new innovative centers of excellence in genomic epidemiology.
The US market dominated the North America Omics Lab Services Market by Country in 2021; thereby, achieving a market value of $37.6 billion by 2028. The Canada market is anticipated to grow at a CAGR of 15% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 13.9% during (2022-2028).
Based on Business, the market is segmented into Diagnostic Labs, Research Institutes, and Hospitals. Based on End-use, the market is segmented into Cancer, Pharmaco, Population Studies & Genealogy, Reproductive, Skincare, Nutrition, Vitamin & Supplements, and Forensics & Others. Based on Type, the market is segmented into Proteomics, Transcriptomic, Metabolomics, Genomics, and Epigenetics. Based on Product, the market is segmented into Hardware Equipment, Testing / Lab Services, and Analytics / Interpretation. Based on Frequency of Service, the market is segmented into Continuous, Repeat, and One-off. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Qiagen N.V., Quest Diagnostics Incorporated, Illumina, Inc., BGI Group, Q2 Solutions (IQVIA), Flomics Biotech, PhenoSwitch Bioscience
The Omics research has mostly helped the area of cancer, and one recently established use of NGS clinical testing is for the measurement of circulating tumor DNA (ctDNA) from plasma. There are several NGS technologies that may be applied, including Cancer Personalized Profiling by deep sequencing. Recent advancements in high-throughput RNA sequencing have highlighted the significance of transcriptomics in biological and clinical research. Transcriptomics may be carried out utilizing microarrays or RNA sequencing using NGS technology.
Omics labs have become an essential tool for the prognosis, diagnosis, and treatment of a wide range of diseases; however, the sample sent to omics labs are significantly impacted by supply chain and logistics issues, a lack of skilled professionals with the capacity to handle samples and these issues. Tens of thousands to millions of molecular measurements may be found in omics databases.
Usually, researchers begin by making feature selection, which entails selecting a subset of the data that seem to be connected to the characteristic or outcome or that are presumed to be physiologically relevant based on prior experience. Using just this subset of the data, a fully described computer model may be developed to forecast the clinical outcome based on the omics measurements.
North America is witnessing a massive adoption of new sequencing technology and a shift toward tailored medications. In addition, government assistance is critical. For example, the Biden Administration announced a USD 1.7 billion investment to Fight COVID-19 Variants in April 2021, with USD 1 billion going to expand genomic sequencing and USD 400 million going to support innovation initiatives like the launch of new innovative centers of excellence in genomic epidemiology.
The US market dominated the North America Omics Lab Services Market by Country in 2021; thereby, achieving a market value of $37.6 billion by 2028. The Canada market is anticipated to grow at a CAGR of 15% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 13.9% during (2022-2028).
Based on Business, the market is segmented into Diagnostic Labs, Research Institutes, and Hospitals. Based on End-use, the market is segmented into Cancer, Pharmaco, Population Studies & Genealogy, Reproductive, Skincare, Nutrition, Vitamin & Supplements, and Forensics & Others. Based on Type, the market is segmented into Proteomics, Transcriptomic, Metabolomics, Genomics, and Epigenetics. Based on Product, the market is segmented into Hardware Equipment, Testing / Lab Services, and Analytics / Interpretation. Based on Frequency of Service, the market is segmented into Continuous, Repeat, and One-off. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Qiagen N.V., Quest Diagnostics Incorporated, Illumina, Inc., BGI Group, Q2 Solutions (IQVIA), Flomics Biotech, PhenoSwitch Bioscience
Scope of the Study
By Business
- Diagnostic Labs
- Research Institutes
- Hospitals
By End-Use
- Cancer
- Pharmaco
- Population Studies & Genealogy
- Reproductive
- Skincare
- Nutrition, Vitamin & Supplements
- Forensics & Others
By Type
- Proteomics
- Transcriptomic
- Metabolomics
- Genomics
- Epigenetics
By Product
- Hardware Equipment
- Testing / Lab Services
- Analytics / Interpretation
By Frequency of Service
- Continuous
- Repeat
- One-off
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Quest Diagnostics Incorporated
- Illumina, Inc.
- BGI Group
- Q2 Solutions (IQVIA)
- Flomics Biotech
- PhenoSwitch Bioscience
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Omics Lab Services Market by Business
Chapter 5. North America Omics Lab Services Market by End-Use
Chapter 6. North America Omics Lab Services Market by Type
Chapter 7. North America Omics Lab Services Market by Product
Chapter 8. North America Omics Lab Services Market by Frequency of Service
Chapter 9. North America Omics Lab Services Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Quest Diagnostics Incorporated
- Illumina, Inc.
- BGI Group
- Q2 Solutions (IQVIA)
- Flomics Biotech
- PhenoSwitch Bioscience
Methodology
LOADING...
Related Reports
From
North America Diagnostic Labs Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - By Lab Type, Testing Services and Revenue Source
- Report
- 152 Pages
- Region: North America
From
![Diagnostic Labs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Lab Type, Testing Services [Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, Non-invasive Prenatal Testing, COVID-19 Testing, and Others], Revenue - Product Image](http://www.researchandmarkets.com/product_images/12326/12326338_60px_jpg/diagnostic_labs_market.jpg)
Diagnostic Labs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Lab Type, Testing Services [Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, Non-invasive Prenatal Testing, COVID-19 Testing, and Others], Revenue
- Report
- 218 Pages
- Region: Global
From
Analytical Laboratory Services Market Research Report by Types of Services, End-User, Country - North America Forecast to 2027 - Cumulative Impact of COVID-19
- Report
- 134 Pages
- Region: North America
From
Clinical Laboratory Services - Global Market Trajectory & Analytics
- Report
- 494 Pages
- Region: Global
From
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
